Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001398344-25-002123·NovaBay Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
NovaBay Pharmaceuticals Inc
Common Stock, par value $0.01 par value · CUSIP: 66987P409
Event date: 2025-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Poplar Point Capital Management LLC
Shares: 620,685.00 · Class: 12.7%
- Poplar Point Capital Partners LP
Shares: 620,685.00 · Class: 12.7%
- Poplar Point Capital GP LLC
Shares: 620,685.00 · Class: 12.7%
- Jad Fakhry
Shares: 620,685.00 · Class: 12.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001398344-25-002123
- Form type
- SCHEDULE 13G/A
- Filer
- NovaBay Pharmaceuticals, Inc.
- CIK
- CIK 1389545
- Filed
- Feb 06, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership